B. Translation of RNA into protein. D. Epigenetic modifications of proteins. C. Specific characteristics and function carried out by proteins. E. All of the above answers are correct. F. Only answers A, B, and C, are correct (but NOT D) A. Reading of the DNA and synthesis of RNA.

B. Translation of RNA into protein. D. Epigenetic modifications of proteins. C. Specific characteristics and function carried out by proteins. E. All of the above answers are correct. F. Only answers A, B, and C, are correct (but NOT D) A. Reading of the DNA and synthesis of RNA.

Concepts of Biology

1st Edition

ISBN:9781938168116

Author:Samantha Fowler, Rebecca Roush, James Wise

Publisher:Samantha Fowler, Rebecca Roush, James Wise

Chapter9: Molecular Biology

Section: Chapter Questions

Problem 11RQ: Post-translational control refers to: a. regulation of gene expression after transcription b....

See similar textbooks

Related questions

Q: Define transcription and translation. Give 3 ways in which they are similar and 3 ways in which they…

A: Central dogma of life is given by Francis crick in 1985.It gives an idea about flow of genetic…

Q: Describe how controlling gene expression will alter the overall protein levels in the cell.

A: The cell controls which proteins are expressed and to what level each protein is expressed in the…

Q: The complex set of chemical markers and genetic switches that regulate gene function is called the

A: The regulatory network components of the genes are called genetic switches. They help to switch on…

Q: define

A: Introduction:- Transcription and translation are processes a cell uses to make all proteins the…

Q: Define transcription unit.

A: Transcription unit is a stretch of DNA that encodes a single RNA molecule and other sequences…

Q: A transcriptional activator protein regulates gene expression in a) cisb) trans

A: The objective of the question is to understand how a transcriptional activator protein regulates…

Q: A) List the steps for gene expression in prokaryotes and eukaryotes. B) Relate the differences in…

A: The gene expression the process in which the genetic information present in the DNA (gene) is copied…

Q: Explain

A: The process by which information encoded in a gene is used to control the assembly of a protein…

Q: Explain how a mutation within a non-coding sequence may alter gene function.

A: Deoxy ribonucleic acid (DNA) is the genetic material of most organisms that carry coded genetic…

Q: Expression of a gene, in terms of greater accumulation of the protein it encodes, could be increased…

A: Often biomolecules like protein are produced in our body for any bodily functions. They are specific…

Q: define gene mutation.

A: Genetic material is nothing but the sequence of nucleic acids which is called as DNA. It contains…

Q: Name six different levels at which gene expression might be controlled.

A: The encoding of proteins by a gene that regulates cellular functions is known as gene expression.…

Q: When regulatory protein binds to a mature mRNA in the cytoplasm and prevents it from binding to a…

A: Translational regulation is the mechanism that aims to control the levels of protein synthesis from…

Q: you think the process could be regulated? Select all that apply: a) Before transcription begins.…

A: Gene expression is the process by which information from a gene is synthesised. The synthesis of a…

Q: Describe what a pseudogene is and what impact they have on gene expression

A: A pseudogene is a nonfunctional gene that can be compared to junk DNA.

Q: Discuss the relationship between genes and phenotype in terms of gene expression and the symptoms…

A: Units of inheritance are called genes. Genes are the DNA regions that encode proteins. Each gene…

Question

The process of gene expression involves:

B. Translation of RNA into protein.
D. Epigenetic modifications of proteins.
C. Specific characteristics and function carried out by proteins.
E. All of the above answers are correct.
F. Only answers A, B, and C, are correct (but NOT D)
A. Reading of the DNA and synthesis of RNA.

Expert Solution

This question has been solved!

Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.

SEE SOLUTION Check out a sample Q&A here

Step 1

VIEW

Step 2

VIEW

Step by step

Solved in 2 steps with 1 images

SEE SOLUTION Check out a sample Q&A here

Knowledge Booster

Learn more about

Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.

Similar questions

Although it is well known that X-rays cause mutations, they are routinely used to diagnose medical problems, including potential tumors, broken bones, and dental cavities. Why is this done? What precautions need to be taken?
Control of gene expression in eukaryotic cells occurs at which level(s)? a. only the transcriptional level b. epigenetic and transcriptional levels c. epigenetic, transcriptional, and translational levels d. epigenetic, transcriptional, post-transcriptional, translational, and post-translational levels
A promoter is ______. a. a specific sequence of DNA nucleotides b. a specific sequence of RNA nucleotides c. a protein that binds to DNA d. an enzyme that synthesizes RNA
One unexpected result of the sequencing of the human genome was the finding that mutations in a single gene can be responsible for multiple distinct disorders. For example, mutations in the RET gene can cause two different types of multiple endocrine neoplasias, familial medullary thyroid carcinoma, and Hirschsprung disease. How do you think mutations in a single gene can have such diverse effects?
Give examples of the different classes of mutations that affect the base sequence of DNA in protein encoding genes and explain the effects that each has on the polypeptide produced.
Two genes associated with breast cancer, BRCA1 and BRCA2, were discovered in 1994 and 1995, respectively, and shortly thereafter, were patented by Myriad Genetics, a company based in Utah. Under the patents, testing for mutations in these genes could only be performed by Myriad, at costs from 300 to 3,000. Myriad also patented the process of analyzing the results of such tests, preventing anyone who obtains the sequence of their BRCA genes by other means (which itself would probably be patent infringement) from interpreting the information. The idea that genes can be patented has been a contentious issue from the beginning. Patents are not granted for products of nature, meaning that genes inside the body are not patentable, but biotech companies successfully argued that by removing a gene from the human body, purifying it, and then obtaining its DNA sequence, they created something not found in nature, and which is therefore a patentable invention. The U.S. Patent Office found the argument persuasive, but opponents argue that genes are parts of our bodies and can be identified but not invented. Biotech companies argue that without the protection offered by patents, they would have no incentive for research and development of diagnostic tests. In Europe, patents for BRCA1 and BRCA2 were revoked in 2004 because they did not meet the standards for a patent. After more than a decade of legal disputes, the patents were partially restored in 2008 on a very restricted basis. In the United States, a lawsuit, focused on the patents for the BRCA genes, was filed in May 2009. The suit challenges the basic idea that genes are patentable. In November 2009, the judge ruled that the lawsuit can proceed, and the case is moving forward. In March 2010, a federal court invalidated Myriad Genetics patent on these genes. In August 2011, the U.S. Court of Appeals reversed the lower courts decision and ruled that gene sequences isolated from cells are not a product of nature and are therefore patentable. The case went to the U.S. Supreme Court, which ordered the appeals court to reconsider the case. The Federal Appeals Court did not change its decision, and the case once again, went to the U.S. Supreme Court. A unanimous decision in June 2013 invalidated Myriads patents on the basis that isolating a gene from nature does not make it patentable. This is a landmark decision on gene patenting with widespread ramifications for the biotechnoloogy industry. Will this decision reduce the incentives for companies to invest in new diagnostic tests that would be used by cancer victims or those with serious genetic disorders?
Figure 15.13 Errors in splicing are implicated in cancers and other human diseases. What kinds of mutations might lead to splicing errors? Think of different possible outcomes if splicing errors occur.
The Adaptive Immune Response Is a Specific Defense Against Infection In cystic fibrosis gene therapy, scientists propose the use of viral vectors to deliver normal genes to cells in the lungs. What immunological risks are involved in this procedure?
If the coding region of a gene (the exons) contains 2,100 base pairs of DNA, would a missense mutation cause a protein to be shorter, longer, or the same length as the normal 700 amino acid proteins? What would be the effect of a nonsense mutation? A sense mutation?
Binding of _______ to _______ in DNA can increase the rate of transcription of specific genes. a. activators; repressors c. repressors; operators b. activators; enhancers d. repressors; enhancers
Mechanisms that govern gene expression do not operate during _______. a. transcription c. translation b. RNA processing d. knockouts
Which of the following is an example of positive control? (a) transcription occurs when a repressor binds to an inducer (b) transcription cannot occur when a repressor binds to a corepressor (c) transcription is stimulated when an activator protein binds to DNA (d) a and b (e) a and c